id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-P-6099-0005,FDA,FDA-2019-P-6099,Final Response from FDA CBER to Patients for Access to Advanced Therapy for Hemophilia (PAATH),Other,Denial of Petition,2020-10-01T04:00:00Z,2020,10,2020-10-01T04:00:00Z,,2020-10-01T19:16:01Z,,0,0,09000064848af559
FDA-2019-P-6099-0004,FDA,FDA-2019-P-6099,Interim Response from FDA CBER to Public Citizen,Other,Letter(s),2020-06-08T04:00:00Z,2020,6,2020-06-08T04:00:00Z,,2020-06-08T20:41:22Z,,0,0,09000064846d6fcc
FDA-2019-P-6099-0003,FDA,FDA-2019-P-6099,Letter from George M. Stone on behalf of Patients for Access to Advanced Therapy for Hemophilia,Other,Letter(s),2020-04-17T04:00:00Z,2020,4,2020-04-17T04:00:00Z,,2020-04-17T18:13:48Z,,0,0,09000064844ad201